BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 1991-02, Vol.35 (2), p.305-308
Hauptverfasser: RICHMAN, D, ROSENTHAL, A. S, SKOOG, M, ECKNER, R. J, TING-CHAO CHOU, SABO, J. P, MERLUZZI, V. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 308
container_issue 2
container_start_page 305
container_title Antimicrobial Agents and Chemotherapy
container_volume 35
creator RICHMAN, D
ROSENTHAL, A. S
SKOOG, M
ECKNER, R. J
TING-CHAO CHOU
SABO, J. P
MERLUZZI, V. J
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.35.2.305
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_aac_35_2_305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15832184</sourcerecordid><originalsourceid>FETCH-LOGICAL-a498t-a7ad1a68ec0fe7cb108143871f7004dcc710b5dbd2e595d973f0d50c1578f7513</originalsourceid><addsrcrecordid>eNp1kcFrFDEYxYNY6rZ68yrkolBw1mRmMkkOHtZF20KhUPQcvk0yOykzmTXJbFn_eiOzuPXgKYT3e--RPITeUrKktBSfVqv1smLLclkR9gItKJGiaJhsXqIFIU1T1ILUr9BFjI8k35kk5-icciIkbxYofbktHq4LJjh2EYNObm8xbMH5mPAvZ8b9ZJy3RbDRxQQ-4W4awGM3DJMfjW2ddtbrA967MEWcDjuLKQZvcDx4G7bZ5DR-cql7lvYanbXQR_vmeF6iH9--fl_fFHf317fr1V0BtRSpAA6GQiOsJq3lekOJoHUlOG05IbXRmlOyYWZjSsskM5JXLTGMaMq4aDmj1SX6POfups1gjbY-BejVLrgBwkGN4NS_ined2o57Vda1lE32fzj6w_hzsjGpwUVt-x68HaeoKBNVSUWdwY8zqMMYY7Dt3w5K1J-RVB5JVUyVKo-U8asZhziU6nGcgs_f8D_23fM3nILnBbP-_qhD1NC3Abx28YTJhnIhqszhmevctntywapcrgD0qeo3_CKzyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15832184</pqid></control><display><type>article</type><title>BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>RICHMAN, D ; ROSENTHAL, A. S ; SKOOG, M ; ECKNER, R. J ; TING-CHAO CHOU ; SABO, J. P ; MERLUZZI, V. J</creator><creatorcontrib>RICHMAN, D ; ROSENTHAL, A. S ; SKOOG, M ; ECKNER, R. J ; TING-CHAO CHOU ; SABO, J. P ; MERLUZZI, V. J</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.35.2.305</identifier><identifier>PMID: 1708976</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antigens, Viral - immunology ; Antiviral Agents ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cytopathogenic Effect, Viral - drug effects ; Drug Resistance, Microbial ; Drug Synergism ; HeLa Cells - drug effects ; HIV-1 ; HIV-1 - drug effects ; HIV-2 - drug effects ; human immunodeficiency virus 1 ; Humans ; Macrophages - drug effects ; Medical sciences ; Nevirapine ; Pharmacology. Drug treatments ; Picornaviridae - drug effects ; Pyridines ; Pyridines - pharmacology ; Research Article ; Reverse Transcriptase Inhibitors ; T-Lymphocytes - drug effects ; Viral Plaque Assay ; Zidovudine ; Zidovudine - pharmacology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1991-02, Vol.35 (2), p.305-308</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a498t-a7ad1a68ec0fe7cb108143871f7004dcc710b5dbd2e595d973f0d50c1578f7513</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC244996/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC244996/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19617883$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1708976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RICHMAN, D</creatorcontrib><creatorcontrib>ROSENTHAL, A. S</creatorcontrib><creatorcontrib>SKOOG, M</creatorcontrib><creatorcontrib>ECKNER, R. J</creatorcontrib><creatorcontrib>TING-CHAO CHOU</creatorcontrib><creatorcontrib>SABO, J. P</creatorcontrib><creatorcontrib>MERLUZZI, V. J</creatorcontrib><title>BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antigens, Viral - immunology</subject><subject>Antiviral Agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cytopathogenic Effect, Viral - drug effects</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Synergism</subject><subject>HeLa Cells - drug effects</subject><subject>HIV-1</subject><subject>HIV-1 - drug effects</subject><subject>HIV-2 - drug effects</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Macrophages - drug effects</subject><subject>Medical sciences</subject><subject>Nevirapine</subject><subject>Pharmacology. Drug treatments</subject><subject>Picornaviridae - drug effects</subject><subject>Pyridines</subject><subject>Pyridines - pharmacology</subject><subject>Research Article</subject><subject>Reverse Transcriptase Inhibitors</subject><subject>T-Lymphocytes - drug effects</subject><subject>Viral Plaque Assay</subject><subject>Zidovudine</subject><subject>Zidovudine - pharmacology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFrFDEYxYNY6rZ68yrkolBw1mRmMkkOHtZF20KhUPQcvk0yOykzmTXJbFn_eiOzuPXgKYT3e--RPITeUrKktBSfVqv1smLLclkR9gItKJGiaJhsXqIFIU1T1ILUr9BFjI8k35kk5-icciIkbxYofbktHq4LJjh2EYNObm8xbMH5mPAvZ8b9ZJy3RbDRxQQ-4W4awGM3DJMfjW2ddtbrA967MEWcDjuLKQZvcDx4G7bZ5DR-cql7lvYanbXQR_vmeF6iH9--fl_fFHf317fr1V0BtRSpAA6GQiOsJq3lekOJoHUlOG05IbXRmlOyYWZjSsskM5JXLTGMaMq4aDmj1SX6POfups1gjbY-BejVLrgBwkGN4NS_ined2o57Vda1lE32fzj6w_hzsjGpwUVt-x68HaeoKBNVSUWdwY8zqMMYY7Dt3w5K1J-RVB5JVUyVKo-U8asZhziU6nGcgs_f8D_23fM3nILnBbP-_qhD1NC3Abx28YTJhnIhqszhmevctntywapcrgD0qeo3_CKzyg</recordid><startdate>19910201</startdate><enddate>19910201</enddate><creator>RICHMAN, D</creator><creator>ROSENTHAL, A. S</creator><creator>SKOOG, M</creator><creator>ECKNER, R. J</creator><creator>TING-CHAO CHOU</creator><creator>SABO, J. P</creator><creator>MERLUZZI, V. J</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>19910201</creationdate><title>BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine</title><author>RICHMAN, D ; ROSENTHAL, A. S ; SKOOG, M ; ECKNER, R. J ; TING-CHAO CHOU ; SABO, J. P ; MERLUZZI, V. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a498t-a7ad1a68ec0fe7cb108143871f7004dcc710b5dbd2e595d973f0d50c1578f7513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antigens, Viral - immunology</topic><topic>Antiviral Agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cytopathogenic Effect, Viral - drug effects</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Synergism</topic><topic>HeLa Cells - drug effects</topic><topic>HIV-1</topic><topic>HIV-1 - drug effects</topic><topic>HIV-2 - drug effects</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Macrophages - drug effects</topic><topic>Medical sciences</topic><topic>Nevirapine</topic><topic>Pharmacology. Drug treatments</topic><topic>Picornaviridae - drug effects</topic><topic>Pyridines</topic><topic>Pyridines - pharmacology</topic><topic>Research Article</topic><topic>Reverse Transcriptase Inhibitors</topic><topic>T-Lymphocytes - drug effects</topic><topic>Viral Plaque Assay</topic><topic>Zidovudine</topic><topic>Zidovudine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RICHMAN, D</creatorcontrib><creatorcontrib>ROSENTHAL, A. S</creatorcontrib><creatorcontrib>SKOOG, M</creatorcontrib><creatorcontrib>ECKNER, R. J</creatorcontrib><creatorcontrib>TING-CHAO CHOU</creatorcontrib><creatorcontrib>SABO, J. P</creatorcontrib><creatorcontrib>MERLUZZI, V. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RICHMAN, D</au><au>ROSENTHAL, A. S</au><au>SKOOG, M</au><au>ECKNER, R. J</au><au>TING-CHAO CHOU</au><au>SABO, J. P</au><au>MERLUZZI, V. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1991-02-01</date><risdate>1991</risdate><volume>35</volume><issue>2</issue><spage>305</spage><epage>308</epage><pages>305-308</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>1708976</pmid><doi>10.1128/AAC.35.2.305</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 1991-02, Vol.35 (2), p.305-308
issn 0066-4804
1098-6596
language eng
recordid cdi_highwire_asm_aac_35_2_305
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antigens, Viral - immunology
Antiviral Agents
Antiviral Agents - pharmacology
Biological and medical sciences
Cytopathogenic Effect, Viral - drug effects
Drug Resistance, Microbial
Drug Synergism
HeLa Cells - drug effects
HIV-1
HIV-1 - drug effects
HIV-2 - drug effects
human immunodeficiency virus 1
Humans
Macrophages - drug effects
Medical sciences
Nevirapine
Pharmacology. Drug treatments
Picornaviridae - drug effects
Pyridines
Pyridines - pharmacology
Research Article
Reverse Transcriptase Inhibitors
T-Lymphocytes - drug effects
Viral Plaque Assay
Zidovudine
Zidovudine - pharmacology
title BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BI-RG-587%20is%20active%20against%20zidovudine-resistant%20human%20immunodeficiency%20virus%20type%201%20and%20synergistic%20with%20zidovudine&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=RICHMAN,%20D&rft.date=1991-02-01&rft.volume=35&rft.issue=2&rft.spage=305&rft.epage=308&rft.pages=305-308&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.35.2.305&rft_dat=%3Cproquest_highw%3E15832184%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15832184&rft_id=info:pmid/1708976&rfr_iscdi=true